Interscalene Block and Dysfunction Diaphragmatic

• Status: Recruiting
• Trial end date: 2021-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The study seeks to show that interscalene injection of a small volume (<8ml) of ropivacaine at a low concentration (0.1%) reduces the frequency of hemi-diaphragmatic paresis compared to low volume injection at the standard concentration (0.5%) in patients undergoing arthroscopic shoulder surgery with ISB.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Lille
• Treatments: Pharmaceutical Solutions; Ropivacaine

Criteria

Inclusion Criteria:

• orthopedic surgery compatible with interscalene block

• french speaking

• Patient who signed consent to participate in the study

Exclusion Criteria:

• Pregnant woman

• ASA score > 3

• Severe chronic respiratory insufficiency

• COPD >3 or 4 of Gold score

• coagulation trouble

• Allergic to medication involved in the study

• Breastfeeding women